Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Irina Sorokina | Researchclopedia

Back to researchers

Irina Sorokina

Moscow Clinical Scientific Center ORCID

39

Works

326

Citations

7

h-index

6

i10-index

Research Topics

Neutropenia and Cancer Infections Cancer Immunotherapy and Biomarkers CAR-T cell therapy research

Affiliations

Lomonosov Moscow State University2015–2017

Moscow Clinical Scientific Center2022–2025

Institute of Bioorganic Chemistry2013–2013

Siberian Branch of the Russian Academy of Sciences2017–2017

Scientific Research Institute of Healthcare Organization and Medical Management2024–2024

Top Works

Mitotic catastrophe and cancer drug resistance: A link that must to be broken

Tatiana V. Denisenko,Irina Sorokina,et al.

2015107 citations

Topic Modeling

Natural Language Processing Techniques

Histological validation of fast macromolecular proton fraction mapping as a quantitative myelin imaging method in the cuprizone demyelination model

Marina Khodanovich,Irina Sorokina,et al.

201795 citations

Involvement of autophagy in the outcome of mitotic catastrophe

Irina Sorokina,Tatiana V. Denisenko,et al.

201734 citations

Neural machine translation of clinical text: an empirical investigation into multilingual pre-trained language models and transfer-learning

Lifeng Han,Serge Gladkoff,et al.

202421 citations

The Gut Microbiota Impacts Gastrointestinal Cancers through Obesity, Diabetes, and Chronic Inflammation

Konstantin Rumyantsev,Vera Polyakova,et al.

202412 citations

Prevention of febrile neutropenia in oncological patients: real-world data

K. V. Sapozhnikov,Irina Sorokina,et al.

202310 citations

Reactive oxygen species regulate a balance between mitotic catastrophe and apoptosis

Irina Sorokina,Tatiana V. Denisenko,et al.

20169 citations

Efficacy and safety of nurulimab+prolgolimab with continued prolgolimab therapy compared to prolgolimab alone as first-line therapy in patients with unresectable or metastatic melanoma: final results of the phase II OBERTON clinical study

Igor Samoylenko,Lev Demidov,et al.

20236 citations

Defendor: Real-world evidence of primary prolonged G-CSF prophylaxis by empegfilgrastim for relative dose intensity compliance in patients with solid tumors—The primary analysis.

A. V. Snegovoy,Alexander Dergunov,et al.

20223 citations